Vaccine boosters may have reduced effectiveness against the current strain of meningitis, leading to the tragic deaths of two students in Kent. Health authorities are contemplating the provision of additional vaccinations to students at the University of Kent and nearby educational institutions due to confirmed cases of meningitis B. However, experts caution that existing vaccines for this strain may not fully prevent transmission of the lethal bacteria.
The UK Health Security Agency (UKHSA) is actively investigating an outbreak that resulted in two fatalities and several hospitalizations, pledging to disclose the specific strain involved once comprehensive test results are available. Individuals born before 2015 are not automatically shielded against meningitis B unless they have received the vaccine privately, as it was only included in the NHS immunization schedule for infants in 2015.
Dr. David Elliman, Honorary Associate Professor in Child Health at London’s Great Ormond Street Hospital, highlighted the success of vaccination programs in curbing meningococcal diseases, particularly the MenB strain affecting young children and individuals aged 15-24. He emphasized that unlike other meningitis vaccines, the MenB vaccine does not effectively prevent bacterial carriage or offer long-lasting protection against all MenB variants.
Meningitis, an infection impacting the brain lining, can stem from various pathogens, with several vaccines providing some defense against the disease. The focus of the current UKHSA investigation is on the MenB strain following 13 reported meningitis cases, including two fatalities, since mid-March. Notably, the MenB vaccine targets meningococcal group B bacteria, responsible for severe conditions like meningitis and sepsis, and is typically administered to infants at specific intervals.
In contrast, the MenACWY vaccine guards against multiple meningococcal groups A, C, W, and Y, with teenagers aged 14 receiving it. While some nations offer booster MenB vaccinations for adolescents, the UK refrains from this practice due to cost-effectiveness considerations. Health experts suggest that resources might be better allocated towards researching alternative vaccines with broader benefits.
Meningitis B, initially resembling flu symptoms, can rapidly escalate, leading to life-threatening sepsis and permanent neurological damage. The NHS advises immediate medical attention if meningitis or sepsis symptoms are suspected, including high fever, severe headache, neck stiffness, light sensitivity, vomiting, and a distinctive rash.
Remember to seek emergency assistance if meningitis or sepsis is suspected.